🇺🇸 FDA

Intelligence Platform

Patents

Browse 454 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7973045

Anhydrous form of dasatinib and process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968749

Process for preparing and drying solid rasagiline base

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968511

Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964748

Process for preparing intermediates of HMG-CoA reductase inhibitors

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7960586

Purification of armodafinil

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928147

Antimicrobial wash and carrier solutions, and uses thereof

Teva Animal Health, Inc. · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7923215

Process for the measurement of the potency of glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915423

Solid states of pantoprazole sodium, processes for preparing them and processes for prepar

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915412

Process for the synthesis of 9-hydroxy risperidone (paliperidone)

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7910126

Flexible, compressed intravaginal rings, methods of making and using the same, and apparat

TEVA WOMEN'S HEALTH, INC. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7908729

Method for making a lollipop

TEVA WOMEN'S HEALTH, INC. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884208

Crystals of laquinimod sodium, and process for the manufacture thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884226

Purification of rosuvatatin intermediate by thin film evaporation and chemical method

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871993

Tigecycline crystalline forms and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7868169

Crystalline rosuvastatin intermediate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7867515

Orally disintegrating solid dosage forms comprising progestin and methods of making and us

Teva Womans's Health, Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858605

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855176

Reduced volume formulation of glatiramer acetate and methods of administration

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855233

Citrate salt of Rasagiline

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855190

Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen ad

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7842717

DNT-maleate and methods of preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7815942

Rasagiline formulations of improved content uniformity

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7812168

Purification of montelukast

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7784616

Dispenser for progestin used for acute maintenance treatment of DUB

TEVA WOMEN'S HEALTH, INC. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted